S100A9 and glioblastoma: In this study, we found that S100A9 did have significant differences in transcriptional expression between GBM tissues and normal brain tissues by analyzing the public GBM RNA-seq database (TCGA, CGGA, etc.,) and this difference was also reflected in the protein level.